Healthcare | April 07, 2026
Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
Subscribe To Our Newsletter & Stay Updated
